Pfizer CEO Touts $80 Billion In Deals, But 'The Real Test' Is Still Ahead
FROM THE WIRE · FINANCE.YAHOO.COM
Pfizer beat third-quarter expectations and hiked its guidance Tuesday, but a portfolio manager says "the real test (is) still ahead." Continue Reading
Read at the source ↗MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: expected bullishPfizer beat third-quarter expectations and raised its guidance, a positive factor for the stock.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
- 01Pfizer beat third-quarter expectations.
- 02Pfizer hiked its guidance on Tuesday.
- 03A portfolio manager says 'the real test is still ahead'.
NEWS IMPACT AND MARKET REACTIONChange from the reference price
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets